235 East 42 Street
New York, NY 10017
United States
Pfizer, Inc.
SSRN RANKINGS
in Total Papers Downloads
in Total Papers Citations
omicron, effectiveness, waning, booster, third dose, BNT162b2, SARS-CoV-2, COVID-19, United States, test-negative, kaiser
BA.2, BA.1, omicron, effectiveness, BNT162b2, SARS-CoV-2, COVID-19, United States, test-negative, Kaiser Permanente, real-world
effectiveness, waning, booster, third dose, BNT162b2, SARS-CoV-2, COVID-19, United States, cohort, delta
pneumonia, lower respiratory tract infection, cardiac failure, COVID-19, SARS-CoV-2